Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range T Battelino, T Danne, RM Bergenstal, SA Amiel, R Beck, T Biester, E Bosi, ... Diabetes care 42 (8), 1593-1603, 2019 | 3064 | 2019 |
International consensus on use of continuous glucose monitoring T Danne, R Nimri, T Battelino, RM Bergenstal, KL Close, JH DeVries, ... Diabetes care 40 (12), 1631-1640, 2017 | 1904 | 2017 |
The CTLA-4 Gene Region of Chromosome 2q33 Is Linked to, and Associated with, Type 1 Diabetes L Nisticò, R Buzzetti, LE Pritchard, B Van der Auwera, C Giovannini, ... Human molecular genetics 5 (7), 1075-1080, 1996 | 1032 | 1996 |
Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring D Deiss, J Bolinder, JP Riveline, T Battelino, E Bosi, N Tubiana-Rufi, ... Diabetes care 29 (12), 2730-2732, 2006 | 718 | 2006 |
Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin E Bosi, RP Camisasca, C Collober, E Rochotte, AJ Garber Diabetes care 30 (4), 890-895, 2007 | 710 | 2007 |
Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. S Trembleau, G Penna, E Bosi, A Mortara, MK Gately, L Adorini The Journal of experimental medicine 181 (2), 817-821, 1995 | 552 | 1995 |
Increased intestinal permeability precedes clinical onset of type 1 diabetes E Bosi, L Molteni, MG Radaelli, L Folini, I Fermo, E Bazzigaluppi, ... Diabetologia 49, 2824-2827, 2006 | 476 | 2006 |
Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study G Calori, G Lattuada, L Piemonti, MP Garancini, F Ragogna, M Villa, ... Diabetes care 34 (1), 210-215, 2011 | 422 | 2011 |
MeDuSa: a multi-draft based scaffolder E Bosi, B Donati, M Galardini, S Brunetti, MF Sagot, P Lió, P Crescenzi, ... Bioinformatics 31 (15), 2443-2451, 2015 | 396 | 2015 |
Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. E Bonifacio, V Lampasona, S Genovese, M Ferrari, E Bosi Journal of immunology (Baltimore, Md.: 1950) 155 (11), 5419-5426, 1995 | 345 | 1995 |
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy F Ciceri, A Castagna, P Rovere-Querini, F De Cobelli, A Ruggeri, L Galli, ... Clinical immunology 217, 108509, 2020 | 332 | 2020 |
High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes R Buzzetti, S Di Pietro, A Giaccari, A Petrone, M Locatelli, C Suraci, ... Diabetes care 30 (4), 932-938, 2007 | 291 | 2007 |
Fatty liver index and mortality: the Cremona study in the 15th year of follow‐up G Calori, G Lattuada, F Ragogna, MP Garancini, P Crosignani, M Villa, ... Hepatology 54 (1), 145-152, 2011 | 289 | 2011 |
Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes M Battaglia, S Ahmed, MS Anderson, MA Atkinson, D Becker, PJ Bingley, ... Diabetes care 43 (1), 5-12, 2020 | 280 | 2020 |
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity E Bonifacio, S Genovese, S Braghi, E Bazzigaluppi, Y Lampasona, ... Diabetologia 38, 816-822, 1995 | 264 | 1995 |
Comparative genome-scale modelling of Staphylococcus aureus strains identifies strain-specific metabolic capabilities linked to pathogenicity E Bosi, JM Monk, RK Aziz, M Fondi, V Nizet, BØ Palsson Proceedings of the National Academy of Sciences 113 (26), E3801-E3809, 2016 | 249 | 2016 |
Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment‐naive patients with type 2 diabetes mellitus E Bosi, F Dotta, Y Jia, M Goodman Diabetes, Obesity and Metabolism 11 (5), 506-515, 2009 | 243 | 2009 |
Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele ST Bennett, AJ Wilson, L Esposito, N Bouzekri, DE Undlien, F Cucca, ... Nature genetics 17 (3), 350-352, 1997 | 233 | 1997 |
Reduction of circulating neutrophils precedes and accompanies type 1 diabetes A Valle, GM Giamporcaro, M Scavini, A Stabilini, P Grogan, E Bianconi, ... Diabetes 62 (6), 2072-2077, 2013 | 223 | 2013 |
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study R De Lorenzo, C Conte, C Lanzani, F Benedetti, L Roveri, MG Mazza, ... PloS one 15 (10), e0239570, 2020 | 221 | 2020 |